Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

  • dorsaVi Secures Breakthrough Memory Tech to Supercharge Sensor Capabilities
    dorsaVi Secures Breakthrough Memory Tech to Supercharge Sensor Capabilities
    • News

  • Australia’s GDP inches higher in March 2025 quarter
    Australia’s GDP inches higher in March 2025 quarter
    • News

  • Soul Patts and Brickworks Strike $14 Billion Deal to Create a Newly Capitalised ASX-Listed Company
    Soul Patts and Brickworks Strike $14 Billion Deal to Create a Newly Capitalised ASX-Listed Company
    • News

  • TruScreen Secures NZ$2.35M in Fresh Capital to Expand Global Cervical Screening Footprint
    TruScreen Secures NZ$2.35M in Fresh Capital to Expand Global Cervical Screening Footprint
    • News

Never been Healthia: COVID-19 spurs a new breed of patient

  • In News
  • December 21, 2020
  • Tim Boreham
Never been Healthia: COVID-19 spurs a new breed of patient

Is the notion of the typical Australian stacking on the ‘isobars’ and indulging in a few too many ‘lockdown lagers’ during their in-house detention just another case of fake news?

In reality, says Healthia (ASX: HLA) CEO Wesley Coote, incarcerated citizens were more likely to be exercising more often and assiduously holding to their appointments with health professionals such as podiatrists and physiotherapists.

“In Brisbane, where I live, people were walking as a family and exercising more than ever,” Mr Coote says.

“They couldn’t spend money on overseas holidays, so they spent more time looking after themselves and making sure they got to their appointments.”

As deemed essential services, Healthia’s clinics largely kept their doors open during the pandemic, with minimum tweaking of rostering and hours. Mr Coote says the company was also in the right place at the right time because the working-from-home requirement created a new breed of client: those with stiff necks and sore backs from ergonomically poor, makeshift desks and chairs.

In addition, podiatry clinics benefited from folk injuring their feet after exercising more vigorously than usual. With their rhythm of life returning to some semblance of normality, Mr Coote reflects that Australians “were acting less affected” as the lockdowns wore on.

So while Healthia’s business declined up to 30% during the initial national lockdowns in April, it was only 16% off the pace during Victoria’s second wave (where 24 of Healthia’s then 150 clinics were located).

“When one of our Victorian clinics started cancelling and rescheduling appointments, patients rang us to express their frustrations and disappointment that they could not be seen,” he says. “We worked out pretty quickly that they wanted a business as usual approach.”

This ‘keep calm and carry on’ message is also resonating at Healthia’s top corporate echelons. At the company’s (virtual) AGM held on November 30, shareholders were told that organic revenue growth gained 14% in the 2020-21 financial year to date (July 1 to October 31).

The company recorded 1.8% revenue growth for the year to June 30 2020 – or 5.3% excluding the impact of the COVID-hit months of April and May. “With restrictions now easing in Victoria, we are pleased to report that from November these clinics are also trading at pre COVID-19 levels,” Mr Coote told investors.

Elsewhere in the health sector telehealth played a key role in maintaining consumer engagement during the pandemic with many patients using the tool for the first time. Healthia also offered the service, but, interestingly, the take-up was small.

“People preferred to come into the clinic for our services as most of our services are delivered with better clinical outcomes face to face,” Mr Coote says.

“We used it mainly to let the patient know we had safety measures in place for them. It then gave them comfort to come back into the clinic.”

Post-pandemic, Healthia has now broadened its reach into optometry with the $43 million purchase of The Optical Company (TOC). Mr Coote notes that optometrists were hard hit in the national lockdown, as they closed for all but urgent or critical work (less arduous rules were implemented during the later Victorian lockdown).

“They [TOC’s 41outlets] are now seeing really good like-for-like sales growth of +5%.”

Despite the TOC purchase, the company’s biggest to date, management has revised its expected spend on practice acquisitions from $15 million annually, to $20m.

“We still have a lot of acquisition opportunities on the go and we’re likely to acquire one or two a month into the New Year,” Mr Coote says.

“Inquiries [from potential vendors] have increased since COVID-19 and we believe that’s because they are placing a lot more value on being part of a larger group in these uncertain times.

“After all, it’s been a hell of a time for a small business owner.”

 

*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications

  • About
  • Latest Posts
Tim Boreham
Tim Boreham edits The New Criterion
Latest posts by Tim Boreham (see all)
  • Amid dazzling returns, is now the time to join the diamond hunt? - November 10, 2021
  • Two listed ag stocks that promise a bounteous harvest for investors - November 3, 2021
  • ASX-listed e-gaming stocks show promise but are they in the main event? - October 27, 2021
  •  
  •  
  •  
  •  
  • allied healthcare
  • asx hla
  • healthcare
  • healthia
  • HLA
  • physio
  • physiotherapy
  • Wes Coote
  • Wesley Coote
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Tim Boreham
Tim Boreham edits The New Criterion
Latest posts by Tim Boreham (see all)
  • Amid dazzling returns, is now the time to join the diamond hunt? - November 10, 2021
  • Two listed ag stocks that promise a bounteous harvest for investors - November 3, 2021
  • ASX-listed e-gaming stocks show promise but are they in the main event? - October 27, 2021

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Tim Boreham
Tim Boreham edits The New Criterion
Latest posts by Tim Boreham (see all)
  • Amid dazzling returns, is now the time to join the diamond hunt? - November 10, 2021
  • Two listed ag stocks that promise a bounteous harvest for investors - November 3, 2021
  • ASX-listed e-gaming stocks show promise but are they in the main event? - October 27, 2021
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.